** Shares of healthcare products distributor Henry Schein
HSIC.O rise 6.2% to $73.09
** Activist investor Ananym Capital Management is urging
Henry Schein to refresh its board, cut costs, tackle succession
planning and consider selling its medical distribution business
** Ananym argues that Schein needs new board members and
ultimately a new CEO to tackle spending, according to a Reuters
report
** Ananym says medical distribution business sale could
increase stock price by 20%
** Including session's move, stock down 2.1% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))